A promising biological target can look convincing on paper. It may be overexpressed in disease tissue, sit inside a pathway linked to pathology, or emerge repeatedly from genomic and proteomic datasets. None of that proves that changing the target will produce the biological effect researchers expect.That is where experimental probes...
